Yu H. Zhang

Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Three-Dimensional Strain Parameters for Quantifying Replacement Fibrosis in Hypertrophic Cardiomyopathy.

Three-Dimensional Strain Parameters for Quantifying Replacement Fibrosis in Hypertrophic Cardiomyopathy.

Journal: JACC. Asia
Published: February 25, 2026

Value of the 6-Minute Walk Test for Risk Assessment in Patients With Hypertrophic Cardiomyopathy.

Value of the 6-Minute Walk Test for Risk Assessment in Patients With Hypertrophic Cardiomyopathy.

Journal: The Canadian journal of cardiology
Published: April 06, 2025

Cardiac Fibroblast Activation May Precede Myocardial Tissue Remodeling in Hypertrophic Cardiomyopathy.

Cardiac Fibroblast Activation May Precede Myocardial Tissue Remodeling in Hypertrophic Cardiomyopathy.

Journal: JACC. Cardiovascular imaging
Published: March 10, 2025

Assessment of Right Atrial Strain by Echocardiography for Predicting Prognosis in Hypertrophic Cardiomyopathy.

Assessment of Right Atrial Strain by Echocardiography for Predicting Prognosis in Hypertrophic Cardiomyopathy.

Journal: JACC. Asia
Published: February 28, 2025

Air Pollution and Cardiac Biomarkers in Heart Failure: A Scoping Review.

Air Pollution and Cardiac Biomarkers in Heart Failure: A Scoping Review.

Journal: Biomedical and environmental sciences : BES
Published: February 12, 2025

Patterns of left ventricular trabeculation in hypertrophic cardiomyopathy.

Patterns of left ventricular trabeculation in hypertrophic cardiomyopathy.

Journal: BMC medicine
Published: October 03, 2024

Somatic NAP1L1 p.D349E promotes cardiac hypertrophy through cGAS-STING-IFN signaling.

Somatic NAP1L1 p.D349E promotes cardiac hypertrophy through cGAS-STING-IFN signaling.

Journal: Nature communications
Published: April 17, 2024

Role of Biomarkers of Myocardial Injury to Predict Adverse Outcomes in Hypertrophic Cardiomyopathy.

Role of Biomarkers of Myocardial Injury to Predict Adverse Outcomes in Hypertrophic Cardiomyopathy.

Journal: Circulation. Cardiovascular quality and outcomes
Published: January 19, 2024

Functional significance of myocardial activity at 18F-FAPI PET/CT in hypertrophic cardiomyopathy identified by cardiac magnetic resonance feature-tracking strain analysis.

Functional significance of myocardial activity at 18F-FAPI PET/CT in hypertrophic cardiomyopathy identified by cardiac magnetic resonance feature-tracking strain analysis.

Journal: European journal of nuclear medicine and molecular imaging
Published: May 22, 2023

Myocardial Activity at 18F-FAPI PET/CT and Risk for Sudden Cardiac Death in Hypertrophic Cardiomyopathy.

Myocardial Activity at 18F-FAPI PET/CT and Risk for Sudden Cardiac Death in Hypertrophic Cardiomyopathy.

Journal: Radiology
Published: October 11, 2022

Single-cell sequencing reveals that endothelial cells, EndMT cells and mural cells contribute to the pathogenesis of cavernous malformations.

Single-cell sequencing reveals that endothelial cells, EndMT cells and mural cells contribute to the pathogenesis of cavernous malformations.

Journal: Experimental & molecular medicine
Published: September 24, 2022

Cardiac index: A superior parameter of cardiac function than left ventricular ejection fraction in risk stratification of hypertrophic cardiomyopathy.

Cardiac index: A superior parameter of cardiac function than left ventricular ejection fraction in risk stratification of hypertrophic cardiomyopathy.

Journal: Heart rhythm
Published: August 28, 2022
Showing 1-12 of 15

Last Updated: 09/26/2026